Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

IMMUNO CONCEPTS INC

US

Last updated May 23, 2026

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
038271904

Catalogue (387)

Page 7 of 8
DeviceModel / ReferenceRegistriesClassStatus
Fluorescent nDNA Test System 8250.1
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8278-Ro
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8251.4-Ro
FDA UDI
N/AActive
Fluorescent nDNA Test System 3005
FDA UDI
N/AActive
Fluorescent ANA Test System 2003
FDA UDI
N/AActive
Fluorescent ANA Test System 2004
FDA UDI
N/AActive
RELISA® ENA Multiparameter Antibody Screening Test 7096-09
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8313-Ro
FDA UDI
N/AActive
Immuno Concepts 7696-12
FDA UDI
N/AUnknown
Fluorescent ANA Test System 2100
FDA UDI
N/AActive
RELISA® Cardiolipin IgG & IgM Antibody Test 7696-02
FDA UDI
N/AActive
Fluorescent ANA Test System 8172.2
FDA UDI
N/AActive
HEp-2000® Fluorescent ANA-Ro Test System 8096-Ro
FDA UDI
N/AActive
AUTO I.D.® Sm/RNP Autoantibody Test System 6006 (1)
FDA UDI
N/AActive
Histofluor® Rodent LKS Fluorescent Antibody Test System 12004-02 (10)
FDA UDI
N/AActive
Fluorescent nDNA Test System 8299
FDA UDI
N/AActive
Colorzyme® nDNA Test System 5040
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8280-Ro
FDA UDI
N/AActive
Fluorescent nDNA Test System 3021 (1)
FDA UDI
N/AActive
Fluorescent ANA Test System M12 (1)
FDA UDI
N/AUnknown
ANCA BP FA Test System - Ethanol Fixed Substrate - 420 Tests 100420-11
FDA UDI
N/AUnknown
HEp-2000® IgG Fluorescent ANA-Ro Test System 2200G-14-Ro
FDA UDI
N/AActive
Fluorescent nDNA Test System 8227
FDA UDI
N/AActive
ANCA-L Test System 10350L-11
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 2000G-18-Ro
FDA UDI
N/AActive
ANCA Test System 10021-12 (2)
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 2140B-Ro
FDA UDI
N/AActive
ANCA Test System 8310
FDA UDI
N/AActive
HEp-2000® Colorzyme® ANA-Ro Test System 4000-14-Ro
FDA UDI
N/AActive
HEp-2000® Colorzyme® ANA-Ro Test System 8155.1-Ro
FDA UDI
N/AActive
Fluorescent ANA Test System 500
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8232-Ro
FDA UDI
N/AActive
IMMUNO CONCEPTS Substrate Slide Test Systems 1042 Bulk
FDA UDI
N/AActive
RELISA® ENA Multiparameter Antibody Screening Test 7696-09
FDA UDI
N/AActive
Histofluor® Primate Esophagus Autoantibody Fluorescent Test System 12160-01
FDA UDI
N/AActive
AUTO I.D.® Sm/RNP Autoantibody Test System 6050 (1)
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8266.1-Ro
FDA UDI
N/AActive
HEp-2 Fluorescent w/cs ANA Test System 2140B
FDA UDI
N/AActive
Histofluor® Primate Esophagus Autoantibody Fluorescent Test System 12080-01
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 2145G-Ro
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8238-Ro
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 2002CS-14-Ro
FDA UDI
N/AActive
RELISA® Cardiolipin IgG & IgM Antibody Test 8288
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 2672CS-Ro
FDA UDI
N/AActive
FITC Quality Control Slide ™ 1900 (1)
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8267-Ro
FDA UDI
N/AActive
HEp-2000® IgG Fluorescent ANA-Ro Test System 8225.2-Ro
FDA UDI
N/AActive
ANCA-L Test System 10070L-11
FDA UDI
N/AActive
RELISA® ENA Single Well Screening Test 7696-10.Au
FDA UDI
N/AActive
Histofluor® IgA Fluorescent Antibody Test System 12021-01 (1)
FDA UDI
N/AActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (2)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Dec 4, 2008Z-1044-2009—terminated

Samples can occasionally run out of the wells and cross contaminate adjacent wells.

Nov 25, 2008Z-1045-2009—terminated

In certain patient samples, it is difficult to properly discriminate between anti-Sm/RMP positive samples and samples that are only anti-Sm positive.